Endocrinology & metabolism

August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS17
Academic Journal
Presents an abstract of the research manuscript `Hyperthyroidism in children and adolescents: Should radioiodine be the first line therapy?,' by L. Ward, C. Huot et al from the Universite de Montreal.


Related Articles

  • Methimazole.  // AHFS Consumer Medication Information;Feb2020, p1 

    Methimazole is used to treat hyperthyroidism, a condition that occurs when the thyroid gland produces too much thyroid hormone. It is also taken before thyroid surgery or radioactive iodine therapy. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more...

  • Successful radioiodine treatment in a 3 year old child with Graves' disease following antithyroid medication induced neutropenia. Rahman, M.A.S.; Birrell, G.; Stewart, H.; Lucraft, H.; Cheetham, T.D. // Archives of Disease in Childhood;Feb2003, Vol. 88 Issue 2, p158 

    Focuses on the radioiodine treatment of a three-year old child with Graves' disease and mitral valve prolapse. Antithyroid medication-induced neutropenia; Echocardiogram prior to treatment; Management of thyrotoxicosis in childhood.

  • Thyroid surgery for Graves' disease. Toft, Anthony D. // British Medical Journal (Clinical Research Edition);3/5/1983, Vol. 286 Issue 6367, p740 

    Focuses on the effectiveness of thyroid surgery for graves' disease in Great Britain. Characterization of the disease; Use of radioactive iodine in patients of reproductive age; Incidence of postoperative hypothyroidism.

  • Restrained rehabilitation: an approach to children and adolescents with unexplained signs and symptoms. Calvert, P.; Jureidini, J. // Archives of Disease in Childhood;May2003, Vol. 88 Issue 5, p399 

    The validation of treatment approaches for children and adolescents diagnosed with unexplained signs and symptoms is made difficult by the variety of clinical presentations and the different developmental levels of different patients. There is little evidence about what combination of approaches...

  • Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study. Howarth, Douglas; Epstein, Martin; Lan, Linda; Tan, Phillip; Booker, John // European Journal of Nuclear Medicine;2001, Vol. 28 Issue 10, p1489 

    The study was performed under the auspices of the International Atomic Energy Commission, Vienna, Austria, with the aim of determining the optimal minimum therapeutic dose of iodine-131 for Graves' disease. The study was designed as a single-blinded randomised prospective outcome trial....

  • Safety and efficacy of a caspofungin-based combination therapy for treatment of proven or probable aspergillosis in pediatric hematological patients. Cesaro, Simone; Giacchino, Mareva; Locatelli, Franco; Spiller, Monica; Buldini, Barbara; Castellini, Claudia; Caselli, Desire√®; Giraldi, Eugenia; Tucci, Fabio; Tridello, Gloria; Rossi, Mario Renato; Castagnola, Elio // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p28 

    Background: Fungal infections are diagnosed increasingly often in patients affected by hematological diseases and their mortality has remained high. The recent development of new antifungal drugs gives the clinician the possibility to assess the combination of antifungal drugs with in-vitro or...

  • Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine. Ward, Leanne; Huot, Celine // Clinical & Investigative Medicine;Aug99, Vol. 22 Issue 4, p132 

    Objective: To evaluate the efficacy of antithyroid medication in the initial treatment of pediatric Graves' disease and the frequency of use and outcome of radioiodine as second-line therapy. Design: Retrospective review. Setting: Tertiary care children's hospital. Patients: Thirty-three...

  • Radioiodine Therapy for Multinodular Goiter. Apgar, Barbara // American Family Physician;12/1/1999, Vol. 60 Issue 9, p2680 

    Presents an abstract of the study `Radioiodine Therapy for Multinodular Toxic Goiter,' by B. Nygaard et al., which appeared on the June 28, 1999 issue of the `Archives of Internal Medicine.'

  • MEDFAQs.  // Undersea & Hyperbaric Medicine;2017, Vol. 44 Issue 3, p297 

    The article presents questions and answers related to Hyperbaric Oxygen (HBO) treatment including studying the complications of EnzaRadicate, use of the radioisotope Iodine-125, and clinical screening tests recommended before treating patients with HBO2.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics